Dr Gary Waanders

Director, Research

+44 (0) 203 829 5617

Find on Linked In

Gary is an experienced healthcare analyst having worked in the City since early 2001. He joined Zeus in January 2014 and is responsible for research coverage of all our Life Sciences corporate clients which include companies active in biotechnology, specialty pharmaceuticals, medical technology and clinical research services. He has worked on numerous IPOs and M&A mandates in the UK and Europe and has previously worked at Nomura Code Securities and KBC Peel Hunt. Prior to becoming an analyst, he managed an R&D group at a Canadian biotech company and before that he was a post-doctoral fellow at the Ludwig Institute for Cancer Research, Lausanne Branch, Switzerland. His academic training includes an MBA from the University of Durham Business School and a PhD in Immunology from the Faculty of Medicine at Monash University (Australia) where he also obtained a BSc (Hons) in Immunology and Biochemistry.